The mission of the Cancer Vaccine Center is to develop therapeutic vaccines that will enable a person's immune system to destroy cancers. The Center pioneers technologies, integrates immunologic research with translational science, and tests vaccine candidates in clinical trials to create effective cancer vaccines. To accelerate the pace of scientific and clinical progress and to facilitate collaboration, the Center also provides expertise, consultation, and service in areas critical to the development of successful cancer vaccines. Key Center technologies include bioinformatics, nanotechnologies, mass spectrometry, structural biology, immune assessment, immunoproteomics, and immunogenomics. The Center maintains an integrated program of scientific discovery, preclinical vaccine development, and clinical investigation.
Scientific discovery efforts include:
Preclinical vaccine development and clinical investigation efforts include:
Search by last name:
Browse directory of
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: